Key result
Clopidogrel plus ASA is linked to fewer recurrent coronary events after MI versus ASA alone.
Key points are not available for this paper at this time.
Design
Other
Supports dual antiplatelet therapy post-MI to reduce recurrent events; reinforces RCT evidence for clopidogrel plus ASA over ASA alone.
The efficacy of clopidogrel in combination with acetylsalicylic acid (ASA) therapy has been clearly established in well-designed randomized controlled trials that have shown a reduction in recurrent coronary events following acute myocardial infarction, as compared with ASA monotherapy.[1][1]
No takes yet. Share an insight, caveat, or question.
Lau et al. (2009) studied this question. Clopidogrel combined with acetylsalicylic acid reduces recurrent coronary events following acute myocardial infarction compared with acetylsalicylic acid monotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: